TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05672342

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.
“withdrawn”

The sponsor’s own words in the registry.

Life of this trial

202320242025Registered2023-01-03Planned start2024-07-06 (planned)Withdrawn (as of)2024-08-09

Vital statistics

Status
Withdrawn
Phase
Early Phase 1
Sponsor
City of Hope Medical Center
Sponsor type
University, hospital or other
Conditions
Breast Carcinoma; Chemotherapy-Induced Peripheral Neuropathy; Colon Carcinoma
Interventions
Cannabidiol; Delta-8-Tetrahydrocannabinol; Placebo Administration; Questionnaire Administration
Participants
0
Sites
1
Countries
United States

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.